questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protéines adaptatrices de la transduction du signal
Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale
Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale : Questions médicales les plus fréquentes",
"headline": "Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-23",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines adaptatrices de la transduction du signal",
"url": "https://questionsmedicales.fr/mesh/D048868",
"about": {
"@type": "MedicalCondition",
"name": "Protéines adaptatrices de la transduction du signal",
"code": {
"@type": "MedicalCode",
"code": "D048868",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteur-1 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 1",
"url": "https://questionsmedicales.fr/mesh/D047990",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-1 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D047990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-2 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 2",
"url": "https://questionsmedicales.fr/mesh/D047992",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-2 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D047992",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-3 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 3",
"url": "https://questionsmedicales.fr/mesh/D048008",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-3 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D048008",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-4 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 4",
"url": "https://questionsmedicales.fr/mesh/D053449",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-4 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D053449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.906"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-5 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 5",
"url": "https://questionsmedicales.fr/mesh/D048015",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-5 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D048015",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-6 associé aux récepteurs de TNF",
"alternateName": "TNF Receptor-Associated Factor 6",
"url": "https://questionsmedicales.fr/mesh/D048029",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-6 associé aux récepteurs de TNF",
"code": {
"@type": "MedicalCode",
"code": "D048029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.024.500.968"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"alternateName": "Tumor Necrosis Factor Receptor-Associated Peptides and Proteins",
"code": {
"@type": "MedicalCode",
"code": "D047988",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Harald Wajant",
"url": "https://questionsmedicales.fr/author/Harald%20Wajant",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine II, Division of Molecular Internal Medicine, University Hospital Würzburg, Auvera Haus, Grombühlstrasse 12, 97080 Würzburg, Germany."
}
},
{
"@type": "Person",
"name": "Jing Wang",
"url": "https://questionsmedicales.fr/author/Jing%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."
}
},
{
"@type": "Person",
"name": "Isabell Lang",
"url": "https://questionsmedicales.fr/author/Isabell%20Lang",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine II, Division of Molecular Internal Medicine, University Hospital Würzburg, Auvera Haus, Grombühlstrasse 12, 97080 Würzburg, Germany."
}
},
{
"@type": "Person",
"name": "Luisa Di Paola",
"url": "https://questionsmedicales.fr/author/Luisa%20Di%20Paola",
"affiliation": {
"@type": "Organization",
"name": "Department of Engineering, Unit of Chemical-Physics Fundamentals in Chemical Engineering, Università Campus Bio-Medico of Rome, Rome, Italy."
}
},
{
"@type": "Person",
"name": "Chuan-Ju Liu",
"url": "https://questionsmedicales.fr/author/Chuan-Ju%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Orthopedic Surgery, New York University Medical Center, Hospital for Joint Diseases, New York, New York."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Anxiety, body dissatisfaction, and exercise identity: Differentiating between adaptive and compulsive exercise.",
"datePublished": "2023-05-20",
"url": "https://questionsmedicales.fr/article/37235995",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.eatbeh.2023.101755"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intrinsic and extrinsic motivations as moderators of the association between exercise frequency and exercise behavior.",
"datePublished": "2022-07-01",
"url": "https://questionsmedicales.fr/article/35776380",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40519-022-01430-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exercise Dependence and Anxiety in Cross-Trainers, Bodybuilders and Gym Exercisers During COVID19.",
"datePublished": "2022-05-16",
"url": "https://questionsmedicales.fr/article/35574906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00315125221098326"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exercising with Parkinson's: The good, the bad and the need for support to keep exercising. A qualitative study.",
"datePublished": "2022-05-13",
"url": "https://questionsmedicales.fr/article/35549564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/02692155221100884"
}
},
{
"@type": "ScholarlyArticle",
"name": "Added Breathing Resistance during Exercise Impairs Pulmonary Ventilation and Exaggerates Exercise-Induced Hypoxemia Leading to Impaired Aerobic Exercise Performance.",
"datePublished": "2023-05-09",
"url": "https://questionsmedicales.fr/article/37239486",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20105757"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines adaptatrices de la transduction du signal",
"item": "https://questionsmedicales.fr/mesh/D048868"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"item": "https://questionsmedicales.fr/mesh/D047988"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"description": "Comment diagnostiquer une dysrégulation des récepteurs TNF ?\nQuels marqueurs sont utilisés pour le diagnostic ?\nLes imageries sont-elles utiles dans le diagnostic ?\nQuels tests génétiques peuvent être effectués ?\nComment évaluer l'activité des protéines associées ?",
"url": "https://questionsmedicales.fr/mesh/D047988?mesh_terms=Exercise&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"description": "Quels sont les symptômes d'une inflammation chronique ?\nComment se manifeste une réponse immunitaire anormale ?\nQuels signes indiquent une activation excessive des récepteurs TNF ?\nLes symptômes varient-ils selon les individus ?\nQuels symptômes sont associés aux maladies inflammatoires ?",
"url": "https://questionsmedicales.fr/mesh/D047988?mesh_terms=Exercise&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"description": "Comment prévenir les maladies liées aux récepteurs TNF ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue la gestion du stress ?\nLes contrôles médicaux réguliers sont-ils nécessaires ?\nComment l'éducation sur la santé aide-t-elle ?",
"url": "https://questionsmedicales.fr/mesh/D047988?mesh_terms=Exercise&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"description": "Quels traitements ciblent les récepteurs TNF ?\nComment les corticostéroïdes aident-ils ?\nLes thérapies biologiques sont-elles efficaces ?\nQuels sont les effets secondaires des traitements ?\nComment la physiothérapie peut-elle aider ?",
"url": "https://questionsmedicales.fr/mesh/D047988?mesh_terms=Exercise&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"description": "Quelles complications peuvent survenir avec les traitements TNF ?\nLes maladies auto-immunes sont-elles une complication ?\nComment les troubles métaboliques sont-ils liés ?\nLes cancers sont-ils une complication potentielle ?\nQuelles complications cardiovasculaires peuvent survenir ?",
"url": "https://questionsmedicales.fr/mesh/D047988?mesh_terms=Exercise&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines et peptides associés aux récepteurs des facteurs de nécrose tumorale",
"description": "Quels facteurs génétiques influencent les récepteurs TNF ?\nLe tabagisme est-il un facteur de risque ?\nL'obésité influence-t-elle les récepteurs TNF ?\nLe stress psychologique est-il un facteur de risque ?\nL'alimentation joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D047988?mesh_terms=Exercise&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des récepteurs TNF ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies peuvent évaluer l'expression des récepteurs TNF."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de TNF-alpha et d'autres cytokines sont des marqueurs diagnostiques."
}
},
{
"@type": "Question",
"name": "Les imageries sont-elles utiles dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IRM et le scanner peuvent aider à visualiser les inflammations associées."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques peuvent être effectués ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests pour des mutations dans les gènes des récepteurs TNF peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité des protéines associées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'activation cellulaire peuvent mesurer l'activité des protéines associées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une inflammation chronique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, rougeur, chaleur et gonflement dans les tissus affectés."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une réponse immunitaire anormale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des réactions allergiques ou des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une activation excessive des récepteurs TNF ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la fièvre, la fatigue et des douleurs articulaires peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux maladies inflammatoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies inflammatoires peuvent provoquer des douleurs, des raideurs et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux récepteurs TNF ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est essentiel."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles aident à prévenir les infections qui peuvent exacerber les maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la gestion du stress ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion du stress peut réduire l'inflammation et améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils nécessaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de détecter précocement les problèmes liés aux récepteurs TNF."
}
},
{
"@type": "Question",
"name": "Comment l'éducation sur la santé aide-t-elle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle sensibilise aux facteurs de risque et aux signes précoces des maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les récepteurs TNF ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs du TNF, comme l'infliximab, sont utilisés pour traiter diverses maladies."
}
},
{
"@type": "Question",
"name": "Comment les corticostéroïdes aident-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils réduisent l'inflammation en inhibant la réponse immunitaire et l'activité des cytokines."
}
},
{
"@type": "Question",
"name": "Les thérapies biologiques sont-elles efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ciblent spécifiquement les voies inflammatoires et améliorent les symptômes."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure infections, réactions allergiques et troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment la physiothérapie peut-elle aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle améliore la mobilité et réduit la douleur par des exercices adaptés et des techniques manuelles."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les traitements TNF ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections graves et des réactions allergiques peuvent survenir avec les traitements."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activation excessive des récepteurs TNF peut contribuer à des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment les troubles métaboliques sont-ils liés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent entraîner des troubles métaboliques comme le diabète ou l'obésité."
}
},
{
"@type": "Question",
"name": "Les cancers sont-ils une complication potentielle ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements peuvent augmenter le risque de cancers dans certains cas."
}
},
{
"@type": "Question",
"name": "Quelles complications cardiovasculaires peuvent survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies inflammatoires peuvent augmenter le risque de complications cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs génétiques influencent les récepteurs TNF ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des variations génétiques peuvent affecter la réponse aux récepteurs TNF et l'inflammation."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut exacerber l'inflammation et affecter la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "L'obésité influence-t-elle les récepteurs TNF ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est associée à une activation accrue des récepteurs TNF et à l'inflammation."
}
},
{
"@type": "Question",
"name": "Le stress psychologique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver l'inflammation et influencer la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut augmenter l'inflammation et le risque."
}
}
]
}
]
}
Little is known about psychosocial variables that may be differentially associated with compulsive exercise versus adaptive exercise. The current study simultaneously examined associations of exercise...
A total of 446 individuals (50.2 % female) completed reports of compulsive exercise, adaptive exercise, body dissatisfaction, exercise identity, and anxiety via an online survey. Multiple linear regre...
Exercise identity, body dissatisfaction, and anxiety were all significantly associated with compulsive exercise. Only exercise identity and anxiety were significantly associated with adaptive exercise...
Exercise identity emerged as the strongest predictor of both compulsive and adaptive exercise. The simultaneous presence of exercise identity, body dissatisfaction, and anxiety may contribute to high ...
Motivations underlying exercise may contribute to the extent to which exercise is maladaptive, independent of exercise frequency. Extrinsic and intrinsic exercise motivation may independently moderate...
A total of 446 university students (50.9% female; 67.0% White) completed measures of intrinsic and extrinsic exercise motivations, exercise frequency, compulsive exercise, and healthy exercise. Intrin...
Moderation effects of exercise motivation were not supported for compulsive exercise. Only main effects of frequency (b = 0.04, p < 0.01) and extrinsic motivation (b = 0.27, p < 0.01) were observed. I...
Consistent with theory and extant work, extrinsic motivation was associated with compulsive exercise, while intrinsic motivation was associated with healthy exercise. Clinically, assessing the extent ...
Level V, Descriptive Cross-Sectional Study....
The World Health Organization declared the COVID-19 pandemic an international public health emergency in January 2020, and, soon thereafter, a worldwide adoption of quarantine and physical isolation m...
To explore the experiences of people with Parkinson's disease exercising and to determine if the location (home versus centre) or exercising in a group impacted on their experience....
A qualitative study....
Community-dwelling people with mild to moderate Parkinson's disease who had undertaken a 10-week exercise intervention....
Semi-structured interviews were conducted with 17 participants; nine participants had completed 10-weeks of predominately home-based exercise and eight participants had predominately centre-based exce...
Four key themes emerged. Two themes: 'targeted exercise is important when you have Parkinson's disease' and 'support helps me to gain the most from the exercise', were related to exercising with Parki...
Experiences of people with Parkinson's disease when exercising were primarily influenced by the prescription of specific exercise and the support provided. There was no clear preference for the locati...
Protective masks impose variable breathing resistance (BR) on the wearer and may adversely affect exercise performance, yet existing literature shows inconsistent results under different types of mask...
The aim of this study was to examine whether cervical stabilization exercises (CSEs) change the effects of conventional exercises (CEs) in patients with PD....
Twenty-five patients with PD were randomized into two groups. While the experimental group (EG) received CSEs in addition to CEs, the control group (CG) received only CEs. Both programs lasted 8 weeks...
At the end of the study, significant improvement was observed in both groups in terms of trunk rotation angle and pelvic asymmetry, the time parameter of TUG, and the 10MWT (...
CEs and CSEs could improve walking speed and posture in patients with PD, but if CSEs are added to CEs, greater improvements could be achieved in JPS and postural control.(Clinical Trials ID: NCT03854...
In a mass casualty incident (MCI) exercise, live-actor patients (LAPs) simulated different scenarios in the exercise. This study compared the benefit to LAPs with that to exercise players (EPs) and no...
An MCI exercise was conducted in 2018. Emergency department (ED) nurses were assigned as EPs, LAPs, or NPs and asked to attend a pre-exercise lecture. A pre-exercise survey evaluated all ED nurses' ba...
Twenty-nine ED nurses completed both surveys. Confidence improved significantly for both the EP and LAP groups. The DMK of the LAP group improved significantly. EOPF also improved significantly for al...
ED nurses can benefit from participating as LAPs in full-scale MCI exercises. Having ED nurses act as LAPs makes it possible to train more staff in 1 exercise....
Factors associated with improving exercise in ovarian cancer survivors remain unknown. We explored characteristics associated with exercise adherence among women treated for ovarian cancer in the Wome...
We evaluated adherence among women randomized to the WALC exercise intervention (N = 74). Women had to be exercising ≤ 90 min/week and post-treatment. The intervention included 25 telephone-based exer...
Women were 57.3 ± 8.8 years old and 1.7 ± 1.0 years since diagnosis. The mean exercise time over 6 months was 166.0 ± 66.1 min/week, and 64.9% of women met the 150 min/week goal. Women attended 22.8 ±...
Women attending more counseling sessions or with no cancer recurrence during the study were more likely to meet the exercise goal. More research is needed to understand ideal counseling intensity for ...
Eighteen counseling sessions are sufficient for ovarian cancer survivors to achieve 150 min/week exercise....
We previously found that a 10-min bout of moderate-intensity exercise (50% maximal oxygen uptake) under normobaric and hypoxic conditions (fraction of inspired oxygen [[Formula: see text]] = 0.135) re...
The aims of the scoping review were to: (1) evaluate how commonly trialists assess and report adherence to exercise intervention for common musculoskeletal conditions and (2) report the levels of adhe...
Medline, Cinahl, Embase, Emcare, and SPORTDiscus databases were searched using predefined terms. Published randomised controlled trials were included. Trials were included if they investigated the eff...
321 trials were included; less than half (46.7%, 150/321) measured adherence. When adherence was assessed, 21% (31/150) of trials did not report the results. Adherence levels were greater when people ...
A majority of trials investigating exercise interventions for common musculoskeletal conditions do not assess exercise adherence. Trials that were registered reported exercise adherence more frequentl...